| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.32 | 4e-10 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.31 | 3e-08 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.27 | 3e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.23 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |